Loxo Oncology to Present at Upcoming Investor Conferences – GlobeNewswire (press release)

Posted: August 31, 2017 at 2:45 am

August 30, 2017 06:45 ET | Source: Loxo Oncology, Inc.

STAMFORD, Conn., Aug. 30, 2017 (GLOBE NEWSWIRE) — Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced that the company will be participating in the following upcoming investor conferences:

Live webcasts of the panel and presentation will be available athttp://ir.loxooncology.com/.

About Loxo OncologyLoxo Oncology is a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers. Our pipeline focuses on cancers that are uniquely dependent on single gene abnormalities, such that a single drug has the potential to treat the cancer with dramatic effect. We believe that the most selective, purpose-built medicines have the highest probability of maximally inhibiting the intended target, thereby delivering best-in-class disease control and safety. Our management team seeks out experienced industry partners, world-class scientific advisors and innovative clinical-regulatory approaches to deliver new cancer therapies to patients as quickly and efficiently as possible. For more information, please visit the company’s website at http://www.loxooncology.com.

Contacts for Loxo Oncology, Inc.

Company:Jacob S. Van NaardenChief Business Officerjake@loxooncology.com

Investors:Peter RahmerThe Trout Group, LLC646-378-2973prahmer@troutgroup.com

Media:Dan Budwick1AB Media973-271-6085dan@1abmedia.com

Stamford, Connecticut, UNITED STATES

Loxo Oncology, Inc. Logo

LOGO URL | Copy the link below

Formats available:

Go here to see the original:
Loxo Oncology to Present at Upcoming Investor Conferences – GlobeNewswire (press release)

Related Post